A prospective study by Haykowsky et al. [47]analyzed HER2-positive breast cancer patients who did aerobic training during thefirst 4 months of adjuvant trastuzumab, and underwent cardiac magnetic resonancesbefore and after the exercise protocol. This evidence concerns the gene ERBB2 and breast cancer.